Initial research in mice of a novel COVID19 vaccine injected by a fingertipsized patch have shown that it can induce an immune response against the novel COVID19 at such levels that it might prevent infection , US scientists said on Thursday.
When the prototype vaccine or the PittCoVacc tested in mice - it generated what they described as a source of antibodies within two weeks against new Coronavirus.
The Researchers from University of Pittsburgh school of medicine cautioned that it is too early predict whether and how long the immune system will work because the mice have not be tracked for very long yet .
The team of scientists said they hope to start testing the vaccine on the people in the next few months.
The finger tip sized patch of 400 tiny needles which is made out of spike protein and sugar is designed to induce pieces of spike protein into the skin where the immune system is strongest.